Prospective randomised controlled trial of Algisite™ M, Cuticerin™, and Sorbact® as donor site dressings in paediatric split-thickness skin grafts.
Craig Antony McBrideRoy M KimbleKellie A StocktonPublished in: Burns & trauma (2018)
Australia and New Zealand Clinical Trials Register (ACTRN12614000380695).Royal Children's Hospital Human Research Ethics Committee (HREC/14/QRCH/36).University of Queensland Medical Research Ethics Committee (#2014000447).
Keyphrases
- clinical trial
- public health
- big data
- healthcare
- endothelial cells
- study protocol
- intensive care unit
- young adults
- global health
- induced pluripotent stem cells
- optical coherence tomography
- soft tissue
- randomized controlled trial
- machine learning
- adverse drug
- phase ii
- artificial intelligence
- open label
- acute care
- deep learning
- phase iii
- double blind